A Phase I/II Open Label Study to Evaluate the Safety, Cellular Kinetics, and Efficacy of AZD0754, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against STEAP2, in Adult Participants with Metastatic Prostate Cancer